Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01809 |
| Species: | Homo sapiens |
| Position : | chr11:5227000-5227060 |
| Year: | 2023 |
| Title: | Therapeutic adenine base editing of human hematopoietic stem cells |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | glioblastoma |
| PMID: | 36639729 |
| MONDO: | MONDO:0005142 |
| Tissue: | Brain |
| Tissue Ontology ID: | UBERON:0000955 |
| Cell Source: | Primary tumor tissue |
| CVCL ID: | |
| Cell Type: | glioblastoma cell |
| Cell Ontology ID: | CL:0000127 |
| Experiment Type: | Functional perturbation assay, Enhancer activity assay |
| High Throughput Method: | RNA-seq |
| Low Throughput Method: | Adenine base editing, RT-RT-qPCR, RP-HPLC |
| Target gene : | HBG2 |
| TF name : |
| Regulatory State : | Silenced |
| GeneName | Pathway Name | Source | Gene Number |
|---|